OM Vaccination


Children in the U.S. are routinely administered the following vaccinations before age 6 years:

  • Hepatitis B
  • Rotavirus
  • DTaP
    • Diphtheria
    • Tetanus toxoids
    • acellular Pertussis
  • Haemophilus influenzae type b conjugated (HiB)
  • Pneumococcal conjugate (PCV13)
  • Influenza
  • Measles
    • Mumps
    • rubella
  • Varicella
  • Hepatitis A
  • Meningococcal conjugate (quadrivalent)
2022 CDC - Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger

The efficacy of the Pneumococcal conjugate vaccines PCV7 vs PCV13 to reduce the instance of AOM has been demonstrate in several studies:


References:

Kaur R, Morris M, Pichichero ME.(2017) Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era. Pediatrics. 140(3):

Soysal A., Gönüllü E., Yıldız I., Aydemir G., Tunç T., Fırat Y., Erdamar B., Karaböcüoğlu M. (2019). Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey. Human Vaccines and Immunotherapeutics. September 5:1-7

Talathi, S., Gupta, N., Sethuram, S., Khanna, S., & Sitnitskaya, Y. (2017). Otitis Media in Fully Vaccinated Preschool Children in the Pneumococcal Conjugate Vaccine Era. Global pediatric health, 4